RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 78-84

  Nagai, Ryohei ^a   Matsuura, Eri ^a   Hoshika, Yusuke ^a   Nakata, Emi ^a   Nagura, Hironori ^a   Watanabe, Ayako ^a   Komatsu, Norio ^b   Okada, Yoshiaki ^a   Doi, Takefumi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

CD41a; GPIIb; Megakaryocyte; PF4; RUNX1; siRNA; UT7 GM cells

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; POLYPLOIDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE SILENCING; HUMANS; LEUKEMIA; MEGAKARYOCYTES;

EID: 33646418444     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.057     Document Type: Article

References (18)

1. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23 (2004) 4198-4208
2. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
3. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., and Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93 (1996) 3444-3449
4. Asou N. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Crit. Rev. Oncol. Hematol. 45 (2003) 129-150
5. Strom D.K., Nip J., Westendorf J.J., Linggi B., Lutterbach B., Downing J.R., Lenny N., and Hiebert S.W. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J. Biol. Chem. 275 (2000) 3438-3445
6. Bernardin F., and Friedman A.D. AML1 stimulates G1 to S progression via its transactivation domain. Oncogene 21 (2002) 3247-3252
7. Coffman J.A. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol. Int. 27 (2003) 315-324
8. Ichikawa M., Asai T., Saito T., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., and Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10 (2004) 299-304
9. Komatsu N., Kirito K., Shimizu R., Kunitama M., Yamada M., Uchida M., Takatoku M., Eguchi M., and Miura Y. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. Blood 89 (1997) 4021-4033
10. Minami T., Tachibana K., Imanishi T., and Doi T. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression. Eur. J. Biochem. 258 (1998) 879-889
11. Shimizu S., Nagasawa T., Katoh O., Komatsu N., Yokota J., and Morishita K. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem. Biophys. Res. Commun. 292 (2002) 609-616
12. Kikuchi J., Furukawa Y., Iwase S., Terui Y., Nakamura M., Kitagawa S., Kitagawa M., Komatsu N., and Miura Y. Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: involvement of cyclin-dependent kinase inhibitor p21 in polyploidization. Blood 89 (1997) 3980-3990
13. Schulze H., and Shivdasani R.A. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3 (2005) 1717-1724
14. Osato M., Yanagida M., Shigesada K., and Ito Y. Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias. Int. J. Hematol. 74 (2001) 245-251
15. Song W.J., Sullivan M.G., Legare R.D., Hutchings S., Tan X., Kufrin D., Ratajczak J., Resende I.C., Haworth C., Hock R., Loh M., Felix C., Roy D.C., Busque L., Kurnit D., Willman C., Gewirtz A.M., Speck N.A., Bushweller J.H., Li F.P., Gardiner K., Poncz M., Maris J.M., and Gilliland D.G. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23 (1999) 166-175
16. Yanagida M., Osato M., Yamashita N., Liqun H., Jacob B., Wu F., Cao X., Nakamura T., Yokomizo T., Takahashi S., Yamamoto M., Shigesada K., and Ito Y. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene 24 (2005) 4477-4485
17. Lutterbach B., and Hiebert S.W. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245 (2000) 223-235
18. Takahashi S., Harigae H., Kameoka J., Sasaki T., and Kaku M. AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication. Br. J. Haematol. 130 (2005) 428-436